Tag archive for ‘(NYSE:TEVA)’
Jewish Business News On Wednesday, June 4th, 2014

Teva to Acquire Labrys Biologics, Inc.: Novel Migraine Prophylaxis Treatment for up to $825 million

–  Adds Significant New Dimension to Teva’s Growing Pain Care Franchise. Peak sales potential of $2-3 billion. – –   Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) and More...

Wordpress site Developed by Fixing WordPress Problems